CO6270172A2 - Metodo para identificar una proteina streptococcus y composiciones inmunogenicas capaces de provocar una respuesta inmune contra por lo menos dos cepas y/o serotipos de streptococcus - Google Patents

Metodo para identificar una proteina streptococcus y composiciones inmunogenicas capaces de provocar una respuesta inmune contra por lo menos dos cepas y/o serotipos de streptococcus

Info

Publication number
CO6270172A2
CO6270172A2 CO10025154A CO10025154A CO6270172A2 CO 6270172 A2 CO6270172 A2 CO 6270172A2 CO 10025154 A CO10025154 A CO 10025154A CO 10025154 A CO10025154 A CO 10025154A CO 6270172 A2 CO6270172 A2 CO 6270172A2
Authority
CO
Colombia
Prior art keywords
streptococcus
protein
identifying
serotypes
immune response
Prior art date
Application number
CO10025154A
Other languages
English (en)
Spanish (es)
Inventor
Hilda Elizabeth Smith
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of CO6270172A2 publication Critical patent/CO6270172A2/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
CO10025154A 2007-08-06 2010-03-03 Metodo para identificar una proteina streptococcus y composiciones inmunogenicas capaces de provocar una respuesta inmune contra por lo menos dos cepas y/o serotipos de streptococcus CO6270172A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07113844A EP2023143A1 (en) 2007-08-06 2007-08-06 Immunogenic streptococcus proteins

Publications (1)

Publication Number Publication Date
CO6270172A2 true CO6270172A2 (es) 2011-04-20

Family

ID=38890252

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10025154A CO6270172A2 (es) 2007-08-06 2010-03-03 Metodo para identificar una proteina streptococcus y composiciones inmunogenicas capaces de provocar una respuesta inmune contra por lo menos dos cepas y/o serotipos de streptococcus

Country Status (19)

Country Link
US (1) US20100297183A1 (https=)
EP (3) EP2023143A1 (https=)
JP (2) JP5462164B2 (https=)
KR (1) KR20100063706A (https=)
CN (1) CN101821627A (https=)
AR (1) AR067830A1 (https=)
AU (1) AU2008284491A1 (https=)
BR (1) BRPI0815604A2 (https=)
CA (1) CA2695721A1 (https=)
CL (1) CL2008002320A1 (https=)
CO (1) CO6270172A2 (https=)
DK (1) DK2183597T3 (https=)
ES (1) ES2432407T3 (https=)
MX (1) MX2010001482A (https=)
RU (1) RU2518315C2 (https=)
TW (1) TW200911999A (https=)
UA (1) UA103885C2 (https=)
WO (1) WO2009020391A1 (https=)
ZA (1) ZA201000806B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000005378A2 (en) 1998-07-22 2000-02-03 Id-Lelystad Instituut Voor Dierhouderij En Diergezondheid B.V. Streptococcus suis vaccines and diagnostic tests
WO2002061070A2 (en) 2001-02-02 2002-08-08 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes, involved in the virulence of streptococcus suis
GB0818231D0 (en) * 2008-10-06 2008-11-12 Univ Nottingham Composition
KR101943171B1 (ko) 2013-09-19 2019-01-29 조에티스 서비시즈 엘엘씨 유성 아쥬반트
JP2018504381A (ja) * 2014-12-22 2018-02-15 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 細胞透過性ペプチド
EP3365003A1 (en) 2015-10-21 2018-08-29 Minervax APS Immunogenic fusion protein
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
RU2685957C2 (ru) * 2016-12-28 2019-04-23 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Химерный рекомбинантный белок, обладающий протективными свойствами в отношении Streptococcus pyogenes
CA3196872A1 (en) * 2020-12-23 2022-06-30 Chan Zuckerberg Biohub, Inc. Bacteria-engineered to elicit antigen-specific t cells
CN112773891B (zh) * 2021-02-01 2022-03-25 北部湾大学 卵形鲳鲹源无乳链球菌dna疫苗及其制备方法和应用
CN119219752B (zh) * 2024-09-12 2026-04-03 华中农业大学 一种猪链球菌抗原蛋白及其筛选方法及其应用
CN119780429B (zh) * 2024-12-27 2025-12-26 华派生物技术(集团)股份有限公司 一种提高猪圆环病毒2型Cap蛋白抗原琼扩检测灵敏度的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283507A (en) 1990-12-20 1994-02-01 General Electric Company Regenerative braking protection for an electrically-propelled traction vehicle
NL9100510A (nl) * 1991-03-21 1992-10-16 Centraal Diergeneeskundig Inst Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
IT1251435B (it) 1991-09-04 1995-05-09 Sclavo Spa Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono.
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
EP0804582A1 (en) * 1994-05-16 1997-11-05 The Uab Research Foundation $i(STREPTOCOCCUS PNEUMONIAE) CAPSULAR POLYSACCHARIDE GENES AND FLANKING REGIONS
US5681570A (en) * 1995-01-12 1997-10-28 Connaught Laboratories Limited Immunogenic conjugate molecules
EP0750042A1 (fr) * 1995-06-20 1996-12-27 Societe Des Produits Nestle S.A. Bactéries lactiques produisant des exopolysaccharides
JP4108126B2 (ja) 1996-04-26 2008-06-25 リュクスウニヴェルシテート テ レイデン Ｔ細胞ペプチド・エピトープの選択と産生方法および選択したエピトープを組込むワクチン
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
WO2000005378A2 (en) * 1998-07-22 2000-02-03 Id-Lelystad Instituut Voor Dierhouderij En Diergezondheid B.V. Streptococcus suis vaccines and diagnostic tests
ES2322306T3 (es) * 1998-12-21 2009-06-18 Medimmune, Inc. Proteinas de streptpcpccus pneumoniae y fragmentos inmunogenicos para vacunas.
WO2000077178A1 (en) * 1999-06-16 2000-12-21 Boston Biomedical Research Institute IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO
DE60136356D1 (de) * 2000-06-12 2008-12-11 Univ Saskatchewan Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik
EP1205552A1 (en) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence of streptococci, involving ORFs from Streptococcus suis
WO2002061070A2 (en) * 2001-02-02 2002-08-08 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes, involved in the virulence of streptococcus suis
BR0316635A (pt) * 2002-11-26 2005-10-11 Univ Tennessee Res Foundation Molécula de aderência de streptococcus uberis
EP1590368B1 (en) * 2003-01-27 2014-02-26 Københavns Universitet Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
EP2327720A1 (en) * 2003-05-30 2011-06-01 Intercell AG Enterococcus antigens
WO2006048763A1 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
HUE030269T2 (en) * 2006-06-26 2017-04-28 Macrogenics Inc FC RIIB-specific antibodies and methods for their use

Also Published As

Publication number Publication date
JP5462164B2 (ja) 2014-04-02
JP2014095721A (ja) 2014-05-22
CA2695721A1 (en) 2009-02-12
AU2008284491A1 (en) 2009-02-12
DK2183597T3 (da) 2013-10-14
BRPI0815604A2 (pt) 2015-03-03
AR067830A1 (es) 2009-10-21
EP2183597A1 (en) 2010-05-12
EP2183597B1 (en) 2013-07-24
CL2008002320A1 (es) 2009-09-25
CN101821627A (zh) 2010-09-01
MX2010001482A (es) 2010-03-01
UA103885C2 (en) 2013-12-10
KR20100063706A (ko) 2010-06-11
RU2010107878A (ru) 2011-09-20
US20100297183A1 (en) 2010-11-25
ZA201000806B (en) 2010-10-27
WO2009020391A1 (en) 2009-02-12
JP2010535500A (ja) 2010-11-25
EP2023143A1 (en) 2009-02-11
EP2660604A3 (en) 2014-02-12
EP2660604A2 (en) 2013-11-06
TW200911999A (en) 2009-03-16
RU2518315C2 (ru) 2014-06-10
ES2432407T3 (es) 2013-12-03

Similar Documents

Publication Publication Date Title
CO6270172A2 (es) Metodo para identificar una proteina streptococcus y composiciones inmunogenicas capaces de provocar una respuesta inmune contra por lo menos dos cepas y/o serotipos de streptococcus
ES2621211T3 (es) Composiciones inmunogénicas que comprenden polipéptidos de mycobacterium tuberculosis y fusiones de los mismos
BR112012012460A2 (pt) "método de liofilização, composições e kits".
MX378854B (es) Composiciones que comprenden cepas bacterianas.
WO2011008349A3 (en) Methods of identifying infectious disease and assays for identifying infectious disease
MX2019011992A (es) Metodos para detectar se?ales de identificacion de enfermedad o condiciones en fluidos corporales.
MX2007007033A (es) Estreptococus del grupo b.
CO6382137A2 (es) Oligonucleótidos inmunoestimuladores
ES2562774T3 (es) Vacunas para la gripe basadas en el virus del mosaico de la papaya
WO2008108830A8 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
WO2008070229A3 (en) Detection of pathogenic aggregates of protein in a sample by homologous elisa
BR112015009541A2 (pt) novos adjuvantes de mucosa e sistemas de aplicação
ES2531115T3 (es) Combinaciones de clados de RrgB neumocócicos
WO2017083729A3 (en) Fixatives and methods of use
WO2012103337A3 (en) Assays and methods to sequence microbes directly from immune complexes
EP2251035A3 (en) New virulence factors of Streptococcus pneumoniae
CL2008001520A1 (es) Procedimiento para detectar la virulencia de una cepa de helicobacter pylori; y kit de deteccion de dichas cepas
WO2004083448A3 (en) Molecular differences between species of the m.tuberculosis complex
CU24709B1 (es) Ácido nucleico que codifica la proteína de superficie neumocócica a1 (pspa1) truncada, constructo de expresión para la expresión de alto nivel de la misma y vacuna conjugada neumocócica
WO2004029216A3 (en) Diagnosis of invasive mold infection
ECSP11010772A (es) Inhibidor de infección
ES2565930T3 (es) Método para la identificación de especies de gramíneas
WO2007075308A3 (en) Vaccine candidates against johne's disease
BR112014022145A2 (pt) peptídeos de interferência e método para detecção de micro-organismos
WO2007104263A8 (zh) 一种乙型肝炎病毒疫苗增效蛋白及其基因

Legal Events

Date Code Title Description
FC Application refused